HEMISPHERIAN AS
Developing novel small molecule drugs targeting TET2 for aggressive cancers.
Overview
- 5
- Employees
- 269K NOK
- Revenue
- 2020
- Founded
Key Decision Makers
Zeno Albisser
Chief Executive Officer
Wolfram Eichner
Director
Adam Robertson
Chief Scientific Officer
Terezia Prikrylova
Chief Operating Officer
+15 more contacts in Funnelfeedr
Description
Hemispherian is an innovative preclinical pharmaceutical company dedicated to redefining targeted cancer therapeutics. The core focus is developing a novel class of small molecule drugs that specifically target the TET2 enzyme. These compounds are designed as targeted therapies for particularly aggr...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
19 contacts in FunnelfeedrZeno Albisser
Chief Executive Officer
Wolfram Eichner
Director
Adam Robertson
Chief Scientific Officer
Terezia Prikrylova
Chief Operating Officer
Roger Stupp
Chair of Clinical Advisory Board
Michael Lim
Clinical Advisory Board Member
Peter Suenaert
Clinical Development
Monika Hegi
Clinical Advisory Board Member
Paul Lelieveld
Chairman
Frode Vartdal
Director
Dallas Hack
Director
Marek Cichocki
Director Chemistry, Manufacturing and Control
Anna Koptina
Regulatory Affairs Consultant
Einar O. Vik-Mo
Clinical Advisory Board Member
Frans van Dalen
Observer
Isabelle M. Germano
Clinical Advisory Board Member
Other Contacts
Sandra Cantilena
Senior Scientist
Josipa Matic
Medicinal Chemist (H2020 Funded)
Guro Kristoffersen
Scientist
Similar Companies
20 similar companies in Funnelfeedr
One-carbon Therapeutics AB
4 employeesClinical-stage biotech pioneering novel anti-cancer therapies targeting metabolism.
ONCOSYNE AS
6 employeesDeveloping cancer treatments using patient-derived 3D tumoroid models.
Double Bond Pharmaceutical AB
5–9 employeesDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
OSLO SCIENCE HUB AS
Accelerating cancer treatment development through collaboration and innovation.
EXACT THERAPEUTICS AS
12 employeesClinical-stage company developing ultrasound-mediated targeted therapy enhancement.
Browse More
HEMISPHERIAN AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo